本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

德康医疗

66.75
+0.29000.44%
成交量:193.46万
成交额:1.29亿
市值:261.76亿
市盈率:46.67
高:67.38
开:66.70
低:66.18
收:66.46
52周最高:93.25
52周最低:57.52
股本:3.92亿
流通股本:3.90亿
量比:0.38
换手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):1.43
每股收益(LYR):1.46
净资产收益率:22.83%
总资产收益率:6.08%
市净率:10.17
市盈率(LYR):45.60

数据加载中...

2025/09/16

重要事件披露

Form 8-K - Current report
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/13

重要事件披露

Form 8-K - Current report
2025/05/09

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/05/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans